PLUS1
108.2901
-2.60 (-2.34%)
-2.60 (-2.34%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Agilent Technologies | A | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -2.60 | -2.34% | 108.2901 | 19:58:53 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 111.40 | 109.56 | 112.42 | 112.21 | 110.89 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 33,509 | 3,252,694 | $ 111.11 | $ 361,410,051 | 1,355,755 | 61.63 - 117.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:58:53 | formt | 200 | $ 108.2901 | USD |
Agilent Technologies Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 33.39B | 308.31M | 307.19M | $ 5.16B | $ 665.51M | 3.37 | 50.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 0.66 | 0.61% | - | - |
Agilent Technologies News
| Date | Time | Source | News Article |
|---|---|---|---|
| 11/23/2020 | 16:08 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 11/23/2020 | 16:05 | Business Wire | Agilent Reports Fourth-Quarter and Fiscal Year 2020.. |
| 11/23/2020 | 12:37 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 11/23/2020 | 12:37 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 11/23/2020 | 12:36 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 11/23/2020 | 12:34 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 11/23/2020 | 12:33 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical A Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 111.00 | 112.42 | 105.19 | 109.19 | 1,987,190 | -2.71 | -2.44% |
| 1 Month | 105.39 | 117.50 | 100.6548 | 108.01 | 1,594,222 | 2.90 | 2.75% |
| 3 Months | 99.90 | 117.50 | 94.76 | 103.91 | 1,267,657 | 8.39 | 8.4% |
| 6 Months | 86.48 | 117.50 | 83.71 | 96.95 | 1,412,882 | 21.81 | 25.22% |
| 1 Year | 79.45 | 117.50 | 61.63 | 85.87 | 1,819,609 | 28.84 | 36.3% |
| 3 Years | 68.84 | 117.50 | 60.42 | 74.63 | 2,046,851 | 39.45 | 57.31% |
| 5 Years | 39.29 | 117.50 | 34.15 | 65.02 | 1,954,072 | 69.00 | 175.62% |
Agilent Technologies Description
| Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2019 sales), cross lab (36% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Just over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (31%) and China (20%) representing the largest country concentrations. |
